{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:06:13Z","timestamp":1759334773004,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.jaad.2004.02.016","type":"journal-article","created":{"date-parts":[[2004,8,31]],"date-time":"2004-08-31T16:30:36Z","timestamp":1093969836000},"page":"463-465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Treatment of glossodynia with olanzapine"],"prefix":"10.1016","volume":"51","author":[{"given":"Carrie L.","family":"Gick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ginat W.","family":"Mirowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John S.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank P.","family":"Bymaster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2004.02.016_BIB1","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0190-9622(92)70136-4","article-title":"Burning mouth syndrome: A possible etiologic role for local contact hypersensitivity","volume":"26","author":"Dutree-Meulenberg","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.02.016_BIB2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0190-9622(96)90840-3","article-title":"The burning mouth syndrome","volume":"34","author":"Huang","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.02.016_BIB3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0190-9622(94)70146-6","article-title":"The burning mouth syndrome: lack of a role for contact urticaria and contact dermatitis","volume":"31","author":"Helton","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.02.016_BIB4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4065\/74.3.223","article-title":"Clinical assessment and outcome in 70 patients with complaints of burning or sore mouth symptoms","volume":"74","author":"Drage","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaad.2004.02.016_BIB5","first-page":"842","article-title":"Burning mouth syndrome: an update","volume":"126","author":"Ship","year":"1995","journal-title":"JADA"},{"key":"10.1016\/j.jaad.2004.02.016_BIB6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/00016480260046535","article-title":"Incidence and treatment of dysgeusia in patients with glossodynia","volume":"546","author":"Tanaka","year":"2002","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.jaad.2004.02.016_BIB7","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0030-4220(91)90162-6","article-title":"Clinical characteristics and management outcome in the burning mouth syndrome: an open study of 130 patients","volume":"72","author":"Gorsky","year":"1991","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.jaad.2004.02.016_BIB8","series-title":"Treatment of skin disease: comprehensive therapeutic strategies","first-page":"237","article-title":"Glossodynia","author":"Drage","year":"2002"},{"first-page":"123","year":"2003","series-title":"Oral pathology: clinical pathologic correlations","key":"10.1016\/j.jaad.2004.02.016_BIB9"},{"key":"10.1016\/j.jaad.2004.02.016_BIB10","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/00006842-199805000-00028","article-title":"Psychiatric comorbidity in patients with burning mouth syndrome","volume":"60","author":"Bogetto","year":"1998","journal-title":"Psychosom Med"},{"key":"10.1016\/j.jaad.2004.02.016_BIB11","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1079-2104(98)90345-6","article-title":"An open-label, dose escalation pilot study of the effect of clonazepam in burning mouth syndrome","volume":"86","author":"Grushka","year":"1998","journal-title":"Oral Surg Oral Med Oral Path Oral Radiol Endod"},{"key":"10.1016\/j.jaad.2004.02.016_BIB12","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1001\/archinte.1996.00040041047001","article-title":"A guide to the understanding and use of tricyclic antidepressants in the overall management of fibromyalgia and other chronic pain syndromes","volume":"156","author":"Godfrey","year":"1996","journal-title":"Arch Int Med"},{"key":"10.1016\/j.jaad.2004.02.016_BIB13","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1212\/WNL.55.7.915","article-title":"Pharmacologic treatment of pain in polyneuropathy","volume":"55","author":"Sindrup","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jaad.2004.02.016_BIB14","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0885-3924(01)00302-5","article-title":"Olanzapine for the treatment of fibromyalgia symptoms","volume":"22","author":"Kiser","year":"2001","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jaad.2004.02.016_BIB15","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0885-3924(02)00378-0","article-title":"Olanzapine in the management of cancer pain","volume":"23","author":"Khojainova","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jaad.2004.02.016_BIB16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0893-133X(94)00129-N","article-title":"Radioreceptor binding profile of the atypical antipsychotic olanzapine","volume":"14","author":"Bymaster","year":"1996","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.jaad.2004.02.016_BIB17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0920-9964(98)00146-7","article-title":"Antagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1and alpha1-adrenergic receptors in vitro","volume":"37","author":"Bymaster","year":"1999","journal-title":"Schizophr Res"},{"key":"10.1016\/j.jaad.2004.02.016_BIB18","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0014-2999(01)01399-1","article-title":"Potent antagonism of 5-HT3 and 5-HT6 receptors by olanzapine","volume":"430","author":"Bymaster","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jaad.2004.02.016_BIB19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0091-3057(99)00107-0","article-title":"The atypical neuroleptics clozapine and olanzapine differ regarding their antinociceptive mechanisms and potency","volume":"64","author":"Schreiber","year":"1999","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.jaad.2004.02.016_BIB20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0014-2999(00)00037-6","article-title":"Decreased binding affinity of olanzapine and clozapine for human muscarinic receptors in intact clonal cells in physiological medium","volume":"390","author":"Bymaster","year":"2000","journal-title":"Eur J Pharmacol"},{"issue":"suppl","key":"10.1016\/j.jaad.2004.02.016_BIB21","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1002\/1099-1166(200112)16:1+<::AID-GPS571>3.0.CO;2-5","article-title":"A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical data","volume":"16","author":"Kennedy","year":"2001","journal-title":"Int J Geriatr Psychiatry"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962204007327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962204007327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T21:36:06Z","timestamp":1759268166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962204007327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0190962204007327"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2004.02.016","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2004,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of glossodynia with olanzapine","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2004.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}